Safety of spinal delivery of riluzole for ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests if giving riluzole directly into the fluid around the spinal cord is safe for people with ALS. It uses a small pump placed under the skin to deliver the medicine continuously.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You can walk with or without a cane or walker
- Your ALS diagnosis is confirmed by doctor
- Your breathing capacity is at least 70% of normal for your age, height, and sex
- You are already taking oral riluzole for at least 30 days and can continue it
- You can have a small pump implanted under your skin to deliver the medicine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding two supplements (EH-301 and N-acetylcysteine) to the standard ALS medicine Riluzole can help slow the disease. It is for people diagnosed with ALS within the last 18 months who still have good breathing and daily function.
This trial tests a new drug called VTx-002 to see if it is safe and tolerable for people with ALS. You may be able to join if you have had symptoms for less than 18 months and have a caregiver who can help.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This study tests an experimental drug called PLL001 for people with ALS. It aims to see if the drug is safe and if it can slow the progression of the disease. You may be a good fit if you have been recently diagnosed and are still in the early stages of ALS.
This trial tests a new drug called TP04HN106 for people with ALS. It aims to see if it is safe and if it might slow down the disease. You may qualify if your breathing is still fairly good and you have been on a stable dose of riluzole.
This trial tests whether injecting neural stem cells into the spine can slow down ALS. It is for people with rapidly progressing ALS who have good lung function and a caregiver to help with visits.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.